NA
PRAH

Navellier & Associates’s PRA Health Sciences, Inc. PRAH Stock Holding History

Navellier & Associates’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-50,362
Closed -$4.63M – 280
2018
Q4 		$4.63M Buy
50,362
+860
+2% +$87K 0.79% 23
2018
Q3 		$5.46M Buy
49,502
+1,222
+3% +$127K 0.71% 37
2018
Q2 		$4.51M Buy
48,280
+2,325
+5% +$200K 0.63% 37
2018
Q1 		$3.81M Buy
45,955
+2,820
+7% +$251K 0.58% 41
2017
Q4 		$3.93M Buy
+43,135
New +$3.59M 0.73% 34
2017
Q1 		– Sell
-60,850
Closed -$3.35M – 322
2016
Q4 		$3.35M Buy
+60,850
New +$3.34M 0.55% 76

Other funds holding PRAH

KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Navellier & Associates's PRAH Position: Q1 2019 in Review

Navellier & Associates sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 50,362 shares — an estimated $4.63M sold.

Navellier & Associates first reported a position in PRAH in Q4 2016 and held it in 6 quarters. The position peaked at $5.46M in Q3 2018. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

  • Navellier & Associates reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
  • Navellier & Associates sold 50,362 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $4.63M.
  • Navellier & Associates first reported a position in PRA Health Sciences, Inc. in Q4 2016 and held it in 6 quarters.
  • Navellier & Associates's PRA Health Sciences, Inc. position peaked at $5.46M in Q3 2018.
  • 354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Navellier & Associates's 13F filing for Q1 2019, filed 15 May 2019.